GAMBARAN DATA KLINIS STRUMA DAN KEGANASAN KELENJAR TIROID DI RSUD CIAWI DAN KOTA BOGOR TAHUN 2018

Main Article Content

Ooki Nico Junior
Fernando Nathaniel
Dean Ascha Wijaya

Abstract

Kanker tiroid merupakan malignansi paling sering pada sistem endokrin. Berdasarkan pada GLOBOCAN tahun 2020, insiden dari kanker tiroid di seluruh dunia adalah 6,6 per 100.000 populasi dengan risiko kumulatif seumur hidup sebesar 0,87%. Penelitian ini bertujuan untuk memberikan gambaran mengenai insidensi struma dan keganasan kelenjar tiroid di RSUD Ciawi dan RSUD Kota Bogor, baik saat masuk rumah sakit maupun saat keluar rumah sakit berdasarkan hasil klinis dan pemeriksaan patologi di RSUD Ciawi/ RSUD Kota Bogor yang dipilih sesuai kriteria secara non random consecutive sampling menggunakan data rekam medis pada periode 2018. Variabel yang digunakan dalam penelitian ini yaitu usia, jenis kelamin, diagnosis saat masuk rumah sakit (struma nodosa non toksik, struma multi nodosa non toksik, struma toksik terkontrol atau karsinoma berdasarkan hasil patologi anatomi) dan diagnosis saat keluar rumah sakit berupa hasil akhir dari patologi anatomi setelah dilakukan pembedahan dan biopsi. Data disajikan dalam bentuk deskriptif. Penelitian ini mengikutsertakan 125 responden dan didominasi oleh perempuan sebesar 107 (85,6%) responden, umumnya berada pada rentang usia 36 hingga 55 tahun pada 68 (54,4%) responden. Diagnosis awal masuk rumah sakit secara klinis umumnya adalah struma nodosa non toksik pada 67 kasus dan karsinoma tiroid pada 43 kasus. Temuan patologi anatomi setelah dilakukan biopsi didominasi oleh PTC dengan varian sebanyak 69 kasus. Hasil penelitian ini menyatakan bahwa kanker tiroid lebih sering terjadi pada perempuan dibandingkan dengan laki-laki dengan predileksi usia paling sering untuk mengalami kanker tiroid adalah dalam rentang 36-55 tahun.

Article Details

Section
Articles

References

Bessey, L. J., Lai, N. B. K., Coorough, N. E., Chen, H., & Sippel, R. S. (2013). The incidence of thyroid cancer by f ine needle aspiration varies by age and gender. Journal of Surgical Research, 184(2), 761–765. https://doi.org/10.1016/j.jss.2013.03.086

Cabanillas, M. E., McFadden, D. G., & Durante, C. (2016). Thyroid Cancer. Lancet, 388, 2783–2795. https://doi.org/http://dx.doi.org/10.1016/

Carling, T., & Udelsman, R. (2014). Thyroid Cancer. Annual Review of Medicine, 65(1), 125–137. https://doi.org/10.1146/annurev-med-061512-105739

Crnčić, T. B., Tomaš, M. I., Girotto, N., & Ivanković, S. G. (2020). Risk Factors for Thyroid Cancer: What Do We Know So Far? Acta Clinica Croatica, 59(1), 66–72. https://doi.org/10.20471/acc.2020.59.s1.08

Daniels, G. H. (2016). Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture? Thyroid, 26(7), 872–874. https://doi.org/10.1089/thy.2016.0244

Deng, Y., Li, H., Wang, M., Li, N., Tian, T., Wu, Y., … Dai, Z. (2020). Global Burden of Thyroid Cancer From 1990 to 2017. JAMA Network Open, 3(6), e208759. https://doi.org/10.1001/jamanetworkopen.2020.8759

Elbalka, S., Metwally, I., Shetiwy, M., Awny, S., Hamdy, O., Kotb, S., … Elzahaby, I. (2021). Prevalence and predictors of thyroid cancer among thyroid nodules: a retrospective cohort study of 1,000 patients. The Annals of The Royal College of Surgeons of England, 103(9), 683–689. https://doi.org/10.1308/rcsann.2021.0057

Giani, C., Torregrossa, L., Piaggi, P., Matrone, A., Viola, D., Molinaro, E., … Elisei, R. (2020). Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up. Endocrine, 68(3), 607–616. https://doi.org/10.1007/s12020-020-02229-0

Hsu, Y.-C., Liu, C.-L., Yang, P.-S., Tsai, C.-H., Lee, J.-J., & Cheng, S.-P. (2016). Interaction of Age at Diagnosis with Transcriptional Profiling in Papillary Thyroid Cancer. World Journal of Surgery, 40(12), 2922–2929. https://doi.org/10.1007/s00268-016-3625-8

International Agency for Research on Cancer. (2020). Thyroid. https://doi.org/https://gco.iarc.fr/today/data/factsheets/cancers/32-Thyroid-fact-sheet.pdf

Jung, C. K., Bychkov, A., & Kakudo, K. (2022). Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach. Endocrinology and Metabolism, 37(5), 703–718. https://doi.org/10.3803/EnM.2022.1553

Jung, C. K., Little, M. P., Lubin, J. H., Brenner, A. V., Wells, S. A., Sigurdson, A. J., & Nikiforov, Y. E. (2014). The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations. The Journal of Clinical Endocrinology & Metabolism, 99(2), E276–E285. https://doi.org/10.1210/jc.2013-2503

Kim, H. J., Kim, N. K., Park, H. K., Byun, D. W., Suh, K., Yoo, M. H., … Chung, J. H. (2017). Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area. European Journal of Nutrition, 56(3), 965–971. https://doi.org/10.1007/s00394-015-1144-2

Kwong, N., Medici, M., Angell, T. E., Liu, X., Marqusee, E., Cibas, E. S., … Alexander, E. K. (2015). The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk. The Journal of Clinical Endocrinology & Metabolism, 100(12), 4434–4440. https://doi.org/10.1210/jc.2015-3100

Li, Y., Jin, C., Li, J., Tong, M., Wang, M., Huang, J., … Ren, G. (2021). Prevalence of Thyroid Nodules in China: A Health Examination Cohort-Based Study. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.676144

Lo, T. E. N., Uy, A. T., & Maningat, P. D. D. (2016). Well-Differentiated Thyroid Cancer: The Philippine General Hospital Experience. Endocrinology and Metabolism, 31(1), 72. https://doi.org/10.3803/EnM.2016.31.1.72

Milano, A. F. (2018). Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Year. Journal of Insurance Medicine, 47(3), 143–158. https://doi.org/10.17849/insm-47-03-143-158.1

Nabhan, F., Dedhia, P. H., & Ringel, M. D. (2021). Thyroid cancer, recent advances in diagnosis and therapy. International Journal of Cancer, 149(5), 984–992. https://doi.org/10.1002/ijc.33690

Petranović Ovčariček, P., Verburg, F. A., Hoffmann, M., Iakovou, I., Mihailovic, J., Vrachimis, A., … Giovanella, L. (2021). Higher thyroid hormone levels and cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48(3), 808–821. https://doi.org/10.1007/s00259-020-05018-z

Prete, A., Borges de Souza, P., Censi, S., Muzza, M., Nucci, N., & Sponziello, M. (2020). Update on Fundamental Mechanisms of Thyroid Cancer. Frontiers in Endocrinology, 11. https://doi.org/10.3389/fendo.2020.00102

Rossi, E. D., Faquin, W. C., & Pantanowitz, L. (2019). Cytologic features of aggressive variants of follicular‐derived thyroid carcinoma. Cancer Cytopathology, 127(7), 432–446. https://doi.org/10.1002/cncy.22136

Seib, C. D., & Sosa, J. A. (2019). Evolving Understanding of the Epidemiology of Thyroid Cancer. Endocrinology and Metabolism Clinics of North America, 48(1), 23–35. https://doi.org/10.1016/j.ecl.2018.10.002

van Gerwen, M., Alpert, N., Sinclair, C., Kale, M., Genden, E., & Taioli, E. (2020). Assessing non-aggressiveness of untreated, local and regional, papillary thyroid cancer. Oral Oncology, 105, 104674. https://doi.org/10.1016/j.oraloncology.2020.104674

Wang, J., Yu, F., Shang, Y., Ping, Z., & Liu, L. (2020). Thyroid cancer: incidence and mortality trends in China, 2005–2015. Endocrine, 68(1), 163–173. https://doi.org/10.1007/s12020-020-02207-6

Yeh, N.-C., Chou, C.-W., Weng, S.-F., Yang, C.-Y., Yen, F.-C., Lee, S.-Y., … Tien, K.-J. (2013). Hyperthyroidism and Thyroid Cancer Risk: A Population-based Cohort Study. Experimental and Clinical Endocrinology & Diabetes, 121(07), 402–406. https://doi.org/10.1055/s-0033-1341474

Zhang, D., Tang, J., Kong, D., Cui, Q., Wang, K., Gong, Y., & Wu, G. (2018). Impact of Gender and Age on the Prognosis of Differentiated Thyroid Carcinoma: a Retrospective Analysis Based on SEER. Hormones and Cancer, 9(5), 361–370. https://doi.org/10.1007/s12672-018-0340-y